Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 29, 2022 08:00 ET | Source: iCAD, Inc.

iCAD Customers in the U.S. and Europe Increasingly Adopting Company’s Full Suite of Breast AI Technologies via Subscription Model

NASHUA, N.H., Aug. 29, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that a...
August 10, 2022 16:07 ET | Source: iCAD, Inc.

iCAD Reports Financial Results For Second Quarter 2022

Company reports accelerating demand for subscription and cloud-based business models driving long-term recurring revenue opportunities Cancer Detection revenue grew 10.4% compared to the second...
July 27, 2022 08:00 ET | Source: iCAD, Inc.

iCAD to Report Second Quarter 2022 Financial Results on August 10, 2022

NASHUA, N.H., July 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
July 13, 2022 08:00 ET | Source: iCAD, Inc.

iCAD Presents its Complete Suite of Breast Cancer AI Solutions at the European Congress of Radiology

NASHUA, N.H., July 13, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the...
June 29, 2022 08:00 ET | Source: iCAD, Inc.

ProFound AI Risk Real-World Case Studies to be featured in iCAD’s “ProFound Insights, ProFound Impact” Webinar Series

NASHUA, N.H., June 29, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
June 07, 2022 08:00 ET | Source: iCAD, Inc.

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Highlight ProFound AI Risk

NASHUA, N.H., June 07, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its next...
June 06, 2022 08:08 ET | Source: iCAD, Inc.

iCAD to Present at the JMP Securities Life Sciences Conference on June 15-16, 2022

NASHUA, N.H., June 06, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company...
May 25, 2022 08:01 ET | Source: iCAD, Inc.

iCAD Announces CFO Transition

NASHUA, N.H., May 25, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board of...
May 18, 2022 08:00 ET | Source: iCAD, Inc.

New Real-World Evidence Shows ProFound AI Improves Cancer Detection and Accuracy with Digital Breast Tomosynthesis, or 3D Mammography

NASHUA, N.H., May 18, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that new...
May 16, 2022 08:00 ET | Source: iCAD, Inc.

New Research Finds iCAD's ProFound AI Risk for Digital Breast Tomosynthesis is 2.4x More Accurate than Traditional Lifetime Risk Models

NASHUA, N.H., May 16, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right